Efficacy and tolerance of gemcitabine-based regimens in elderly patients with advanced pancreatic cancer

被引：0
|
作者：
Marechal, Raphael
Demols, Anne
Gay, France
Arvanitakis, Marianna
Hendlisz, Alain
Van Laethem, Jean-Luc
机构：
[1] Erasme Univ Hosp, B-1070 Brussels, Belgium
[2] Inst Jules Bordet, B-1000 Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：326 / 326
页数：1
相关论文
共 50 条
  • [21] CLINICAL BENEFIT OF GEMCITABINE-BASED CHEMOTHERAPY FOR EXTREME ELDERLY PATIENTS WITH PANCREATIC CANCER: A NATIONWIDE POPULATION-BASED STUDY
    Lee, Dong Wook
    Cho, Chang Min
    GASTROENTEROLOGY, 2023, 164 (06) : S1209 - S1209
  • [22] Genomic Testing for Gemcitabine-Based Treatment of Pancreatic Cancer
    Zhang, Jianliang
    Hochwald, Steven N.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (05):
  • [23] Neoadjuvant chemotherapy with gemcitabine-based regimens improves the prognosis of node positive resectable pancreatic head cancer
    Tajima, Hidehiro
    Ohta, Tetsuo
    Okazaki, Mitsuyoshi
    Yamaguchi, Takahisa
    Ohbatake, Yoshinao
    Okamoto, Koichi
    Nakanuma, Shinichi
    Kinoshita, Jun
    Makino, Isamu
    Nakamura, Keishi
    Miyashita, Tomoharu
    Takamura, Hiroyuki
    Ninomiya, Itasu
    Fushida, Sachio
    Nakamura, Hiroyuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 11 (02) : 157 - 166
  • [24] Patient-reported symptoms from patients with advanced pancreatic cancer undergoing gemcitabine-based chemotherapy.
    Wang, Xin Shelley
    Fogelman, David R.
    Shi, Qiuling
    Eng, Cathy
    Bokhari, Raza H.
    Huang, Furong
    Mobley, Gary M.
    Gilmore, Katherine R.
    Cleeland, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [25] THE EFFICACY OF GEMCITABINE-BASED CHEMORADIOTHERAPY FOR THE DEFINITIVE TREATMENT OF LOCALLY-ADVANCED BLADDER CANCER
    Kurt, M.
    Ozturk, H.
    Cetintas, S.
    Kurt, E.
    Ozkan, L.
    ANNALS OF ONCOLOGY, 2012, 23 : 291 - 291
  • [26] Meta-analysis of randomised trials comparing gemcitabine-based doublets versus gemcitabine alone in patients with advanced and metastatic pancreatic cancer
    Banu, Eugeniu
    Banu, Adela
    Fodor, Andrei
    Landi, Bruno
    Rougier, Philippe
    Chatellier, Gilles
    Andrieu, Jean-Marie
    Oudard, Stephane
    DRUGS & AGING, 2007, 24 (10) : 865 - 879
  • [27] Meta-Analysis of Randomised Trials Comparing Gemcitabine-Based Doublets versus Gemcitabine Alone in Patients with Advanced and Metastatic Pancreatic Cancer
    Eugeniu Banu
    Adela Banu
    Andrei Fodor
    Bruno Landi
    Philippe Rougier
    Gilles Chatellier
    Jean-Marie Andrieu
    Stephane Oudard
    Drugs & Aging, 2007, 24 : 865 - 879
  • [28] Gemcitabine/nabpaclitaxel efficacy in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma
    Michalaki, V.
    Poydorou, A.
    Frangulidis, G.
    Vezakis, A.
    Karvouni, E.
    Papadimitriou, C.
    ANNALS OF ONCOLOGY, 2018, 29 : 44 - 44
  • [29] Safety and efficacy of gemcitabine plus nab-paclitaxel therapy in elderly patients with advanced pancreatic cancer
    Aoki, Yu
    Sukawa, Yasutaka
    Kawasaki, Kenta
    Suzuki, Takeshi
    Hirata, Kenro
    Kasuga, Akiyoshi
    Iwasaki, Eisuke
    Hamamoto, Yasuo
    Takaishi, Hiromasa
    Kanai, Takanori
    ANNALS OF ONCOLOGY, 2017, 28
  • [30] The efficacy and safety of gemcitabine-based combination therapy vs. gemcitabine alone for the treatment of advanced pancreatic cancer: a systematic review and meta-analysis
    Zhang, Zhaohuan
    He, Shuling
    Wang, Ping
    Zhou, Yibing
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, : 1967 - 1980
12345